Clinical trial NCT02528435 - References

Juvenile Idiopathic Arthritis — Understanding Methotrexate Induced Gastrointestinal Intolerance in Juvenile Idiopathic Arthritis and Childhood Leukemia

Citation(s)

•   Beresford MW, Baildam EM
  New advances in the management of juvenile idiopathic arthritis--1: non-biological therapy. Arch Dis Child Educ Pract Ed. 2009 Oct;94(5):144-50. doi: 10.1136/adc.2008.144576. Review.
•   Bulatovic M, Heijstek MW, Verkaaik M, van Dijkhuizen EH, Armbrust W, Hoppenreijs EP, Kamphuis S, Kuis W, Egberts TC, Sinnema G, Rademaker CM, Wulffraat NM
  High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: development and validation of a methotrexate intolerance severity score. Arthritis Rheum. 2011 Jul;63(7):2007-13. doi: 10.1002/art.30367.
•   Campalani E, Arenas M, Marinaki AM, Lewis CM, Barker JN, Smith CH
  Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis. J Invest Dermatol. 2007 Aug;127(8):1860-7. Epub 2007 Apr 5. Erratum in: J Invest Dermatol. 2008 Oct;128(10):2545-6.
•   Dervieux T, Furst D, Lein DO, Capps R, Smith K, Walsh M, Kremer J
  Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Arthritis Rheum. 2004 Sep;50(9):2766-74.
•   Dervieux T, Kremer J, Lein DO, Capps R, Barham R, Meyer G, Smith K, Caldwell J, Furst DE
  Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis. Pharmacogenetics. 2004 Nov;14(11):733-9.
•   Dolgin MJ, Katz ER
  Conditioned aversions in pediatric cancer patients receiving chemotherapy. J Dev Behav Pediatr. 1988 Apr;9(2):82-5.
•   Giannini EH, Ilowite NT, Lovell DJ, Wallace CA, Rabinovich CE, Reiff A, Higgins G, Gottlieb B, Singer NG, Chon Y, Lin SL, Baumgartner SW; Pediatric Rheumatology Collaborative Study Group
  Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum. 2009 Sep;60(9):2794-804. doi: 10.1002/art.24777.
•   Gregers J, Christensen IJ, Dalhoff K, Lausen B, Schroeder H, Rosthoej S, Carlsen N, Schmiegelow K, Peterson C
  The association of reduced folate carrier 80G>A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy number. Blood. 2010 Jun 10;115(23):4671-7. doi: 10.1182/blood-2010-01-256958. Epub 2010 Mar 24.
•   Gutiérrez-Suárez R, Burgos-Vargas R
  The use of methotrexate in children with rheumatic diseases. Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S122-7. Epub 2010 Oct 28.
•   Hashkes PJ, Laxer RM
  Medical treatment of juvenile idiopathic arthritis. JAMA. 2005 Oct 5;294(13):1671-84. Review.
•   Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B
  The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurement. Pain. 2001 Aug;93(2):173-83.
•   Kishi S, Cheng C, French D, Pei D, Das S, Cook EH, Hijiya N, Rizzari C, Rosner GL, Frudakis T, Pui CH, Evans WE, Relling MV
  Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood. 2007 May 15;109(10):4151-7. Epub 2007 Jan 30.
•   Laverdière C, Chiasson S, Costea I, Moghrabi A, Krajinovic M
  Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia. Blood. 2002 Nov 15;100(10):3832-4.
•   Levinsen M, Rosthøj S, Nygaard U, Heldrup J, Harila-Saari A, Jonsson OG, Bechensteen AG, Abrahamsson J, Lausen B, Frandsen TL, Weinshilboum RM, Schmiegelow K
  Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity. Cancer Chemother Pharmacol. 2015 Jan;75(1):59-66. doi: 10.1007/s00280-014-2613-7. Epub 2014 Oct 28.
•   Lopez-Lopez E, Gutierrez-Camino A, Bilbao-Aldaiturriaga N, Pombar-Gomez M, Martin-Guerrero I, Garcia-Orad A
  Pharmacogenetics of childhood acute lymphoblastic leukemia. Pharmacogenomics. 2014 Jul;15(10):1383-98. doi: 10.2217/pgs.14.106. Review.
•   Mikkelsen TS, Thorn CF, Yang JJ, Ulrich CM, French D, Zaza G, Dunnenberger HM, Marsh S, McLeod HL, Giacomini K, Becker ML, Gaedigk R, Leeder JS, Kager L, Relling MV, Evans W, Klein TE, Altman RB
  PharmGKB summary: methotrexate pathway. Pharmacogenet Genomics. 2011 Oct;21(10):679-86. doi: 10.1097/FPC.0b013e328343dd93.
•   Moncrieffe H, Hinks A, Ursu S, Kassoumeri L, Etheridge A, Hubank M, Martin P, Weiler T, Glass DN, Thompson SD, Thomson W, Wedderburn LR
  Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype. Pharmacogenet Genomics. 2010 Nov;20(11):665-76. doi: 10.1097/FPC.0b013e32833f2cd0.
•   Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Straume B, Rygg M; Nordic Study Group of Pediatric Rheumatology
  Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum. 2011 Sep;63(9):2809-18. doi: 10.1002/art.30426.
•   Pui CH, Schrappe M, Ribeiro RC, Niemeyer CM
  Childhood and adolescent lymphoid and myeloid leukemia. Hematology Am Soc Hematol Educ Program. 2004:118-45. Review.
•   Ranganathan P, Culverhouse R, Marsh S, Mody A, Scott-Horton TJ, Brasington R, Joseph A, Reddy V, Eisen S, McLeod HL
  Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. J Rheumatol. 2008 Apr;35(4):572-9. Epub 2008 Mar 15.
•   Rau T, Erney B, Göres R, Eschenhagen T, Beck J, Langer T
  High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations. Clin Pharmacol Ther. 2006 Nov;80(5):468-76.
•   Salliot C, van der Heijde D
  Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis. 2009 Jul;68(7):1100-4. doi: 10.1136/ard.2008.093690. Epub 2008 Dec 5. Review.
•   Schmeling H, Biber D, Heins S, Horneff G
  Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis. J Rheumatol. 2005 Sep;32(9):1832-6.
•   Stamp LK, Chapman PT, O'Donnell JL, Zhang M, James J, Frampton C, Barclay ML, Kennedy MA, Roberts RL
  Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate. Pharmacogenet Genomics. 2010 Jun;20(6):367-76. doi: 10.1097/FPC.0b013e3283398a71.
•   Stamp LK, O'Donnell JL, Chapman PT, Zhang M, James J, Frampton C, Barclay ML
  Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy. Arthritis Rheum. 2010 Feb;62(2):359-68. doi: 10.1002/art.27201.
•   Steinberg SE, Campbell CL, Bleyer WA, Hillman RS
  Enterohepatic circulation of methotrexate in rats in vivo. Cancer Res. 1982 Apr;42(4):1279-82.
•   Thastum M, Herlin T, Zachariae R
  Relationship of pain-coping strategies and pain-specific beliefs to pain experience in children with juvenile idiopathic arthritis. Arthritis Rheum. 2005 Apr 15;53(2):178-84.
•   Thastum M, Herlin T
  Pain-specific beliefs and pain experience in children with juvenile idiopathic arthritis: a longitudinal study. J Rheumatol. 2011 Jan;38(1):155-60. doi: 10.3899/jrheum.091375. Epub 2010 Oct 15.
•   Thastum M, Ravn K, Sommer S, Trillingsgaard A
  Reliability, validity and normative data for the Danish Beck Youth Inventories. Scand J Psychol. 2009 Feb;50(1):47-54. doi: 10.1111/j.1467-9450.2008.00690.x. Epub 2008 Oct 22.
•   Thastum M, Zachariae R, Herlin T
  Pain experience and pain coping strategies in children with juvenile idiopathic arthritis. J Rheumatol. 2001 May;28(5):1091-8.
•   Thastum M, Zachariae R, Schøler M, Herlin T
  A Danish adaptation of the Pain Coping Questionnaire for children: preliminary data concerning reliability and validity. Acta Paediatr. 1999 Feb;88(2):132-8.
•   Treviño LR, Shimasaki N, Yang W, Panetta JC, Cheng C, Pei D, Chan D, Sparreboom A, Giacomini KM, Pui CH, Evans WE, Relling MV
  Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. J Clin Oncol. 2009 Dec 10;27(35):5972-8. doi: 10.1200/JCO.2008.20.4156. Epub 2009 Nov 9.
•   Tyc VL, Mulhern RK, Fairclough D, Ward PM, Relling MV, Longmire W
  Chemotherapy induced nausea and emesis in pediatric cancer patients: external validity of child and parent emesis ratings. J Dev Behav Pediatr. 1993 Aug;14(4):236-41.
•   Tyc VL, Mulhern RK, Jayawardene D, Fairclough D
  Chemotherapy-induced nausea and emesis in pediatric cancer patients: an analysis of coping strategies. J Pain Symptom Manage. 1995 Jul;10(5):338-47.
•   van Ede AE, Laan RF, Blom HJ, Huizinga TW, Haagsma CJ, Giesendorf BA, de Boo TM, van de Putte LB
  The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis Rheum. 2001 Nov;44(11):2525-30.
•   Wallace CA
  The use of methotrexate in childhood rheumatic diseases. Arthritis Rheum. 1998 Mar;41(3):381-91. Review.
•   Watson M, McCarron J, Law M
  Anticipatory nausea and emesis, and psychological morbidity: assessment of prevalence among out-patients on mild to moderate chemotherapy regimens. Br J Cancer. 1992 Nov;66(5):862-6.
•   Watson M, Meyer L, Thomson A, Osofsky S
  Psychological factors predicting nausea and vomiting in breast cancer patients on chemotherapy. Eur J Cancer. 1998 May;34(6):831-7.
•   Wessels JA, de Vries-Bouwstra JK, Heijmans BT, Slagboom PE, Goekoop-Ruiterman YP, Allaart CF, Kerstens PJ, van Zeben D, Breedveld FC, Dijkmans BA, Huizinga TW, Guchelaar HJ
  Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes. Arthritis Rheum. 2006 Apr;54(4):1087-95.
•   Yamakawa Y, Hamada A, Nakashima R, Yuki M, Hirayama C, Kawaguchi T, Saito H
  Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia. Ther Drug Monit. 2011 Apr;33(2):244-50. doi: 10.1097/FTD.0b013e31820beb02.

Role of Pharmacogenetic and Psychological Factors in Methotrexate Tolerance: Studies in Children With Chronic Arthritis and Children With Leukemia

Details for clinical trial NCT02528435